Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.
Share or print this source review
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.
Clinical context remains essential
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
The source wording includes venous hypoxemia; it is preserved rather than silently altered. This high-alert infusion requires current labeling, continuous monitoring and specialist oversight.
Check source scope before reading a dose
GlobalRPh RX List - NIPRIDE RTU
Product / population
Sodium nitroprusside - NIPRIDE RTU renal limits; selected source sections, not a full prescribing monograph.
GlobalRPh-hosted RX List · Sodium nitroprusside - NIPRIDE RTU renal limits; selected source sections, not a full prescribing monograph.
Renal method: eGFR, mL/min/1.73 m2; retain body-surface-area indexing. Source date: Source revision date not established in selected retrieval. Retrieved: 2026-09-08
Label mirror, not independent corroboration. This is selected locally stored RX List content. Full monograph import and current official-label review are not implied.
Dose or interval guidance. Use only the product, indication, renal metric and population described in this source.
Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph.
Renal dosing, restrictions and evidence limits
For eGFR <30 mL/min/1.73 m2, keep the mean infusion rate below 3 mcg/kg/min. For anuric patients, limit the mean rate to 1 mcg/kg/min. These are mean-rate renal limits, not a newly calculated universal instantaneous maximum. Thiocyanate accumulates because its clearance is primarily renal. Hemodialysis may remove thiocyanate in severe toxicity; this does not establish removal of cyanide or routine dialysis supplementation. Cyanide toxicity requires stopping nitroprusside and specific evaluation.
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
GlobalRPh v6.6 | RDM66-DIRECT-PHP-20260911 | Local library date 2026-09-11. Selected-card identity does not imply clinical verification.